Loss of the tRNALys CUU encoding gene, Chr-11 tRNA-Lys-CUU, is not associated with Type 2 diabetes mellitus
Abstract
Aim: To investigate the presence/absence of the Chr-11 tRNA-Lys-CUU gene as a marker for genetic predisposition to Type 2 diabetes mellitus (T2DM). Methods: We enrolled 122 patients diagnosed with T2DM and 77 non-diabetic individuals. We evaluated clinical and biochemical parameters (body mass index, hypertension, cholesterol levels, glycosylated hemoglobin, triglycerides, etc.), and performed a genotypic profiling of Chr-11 tRNA-Lys-CUU by polymerase chain reaction analyses. Results: Approximately one third of the population lacked Chr-11 tRNA-Lys-CUU. We did not observe a statistically significant association between the presence/absence of Chr-11 tRNA-Lys-CUU and T2DM. Conclusion: The genotypic distribution of Chr-11 tRNA-Lys-CUU in our population was consistent to that reported by others. This gene failed as a marker for T2DM predisposition.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1 IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res. Clin. Pract. 138, 271–281 (2018). •• A global analysis indicating the importance and prevalence of Type 2 diabetes mellitus (T2DM) in the human population.
- 2 American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 37(Suppl. 1), S81–90 (2014).
- 3 . Early diagnosis and prevention of diabetes in developing countries. Rev. Endocr. Metab. Disord. 9(3), 193–201 (2008).
- 4 . Biogenesis and Evolution of Functional tRNAs. In: Fungal RNA Biology. Sesma A, Von der Haar T (Eds). Springer International Publishing, Switzerland, 233–267 (2014).
- 5 . Role of tRNA modifications in human diseases. Trends Mol. Med. 20(6), 306–314 (2014). •• A systematic review that describes defects in genes encoding tRNA modification enzymes associated to T2DM.
- 6 . Transfer RNA and human disease. Front. Genet. 5, 158 (2014).
- 7 Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted Type II diabetes mellitus and deafness. Nat. Genet. 1(5), 368–371 (1992). • To the best of our knowledge, this is the first article describing defects on tRNA biology associated to Type 2 diabetes mellitus (T2DM).
- 8 Evidence that the mitochondrial leucyl tRNA synthetase (LARS2) gene represents a novel Type 2 diabetes susceptibility gene. Diabetes. 54(6), 1892–1895 (2005).
- 9 . Quantitative PCR measurement of tRNA 2-methylthio modification for assessing Type 2 diabetes risk. Clin. Chem. 59(11), 1604–1612 (2013).
- 10 Genome-wide association analysis identifies loci for Type 2 diabetes and triglyceride levels. Science 316(5829), 1331–1336 (2007).
- 11 A variant in CDKAL1 influences insulin response and risk of Type 2 diabetes. Nat. Genet. 39(6), 770–775 (2007).
- 12 . Functional loss of Cdkal1, a novel tRNA modification enzyme, causes the development of Type 2 diabetes. Endocr. J. 58(10), 819–825 (2011).
- 13 . Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene. Rev. Endocr. Metab. Disord. 11(3), 205–215 (2010).
- 14 . tRNA gene copy number variation in humans. Gene. 536(2), 376–384 (2014). •• A thorough analysis using data from the 1000 genomes project that reports for the first time the genotipyc variation of Chr-11 tRNA-Lys-CUU in humans and propose its potential role in T2DM.
- 15 . Different types of secondary information in the genetic code. RNA. 20(7), 977–984 (2014).
- 16 . The effect of dysregulation of tRNA genes and translation efficiency mutations in cancer and neurodegeneration. Front. Genet. 3, 201 (2012).
- 17 . Blood pressure lipids and glucose in Type 2 diabetes: how low should we go? Re-discovering personalized care. Eur. Heart. J. 32(18), 2247–2255 (2011).
- 18 . Metabolic syndrome. In: StatPearls. Zeltser R (Ed.). StatPearls Publishing, Treasure Island, FL, USA (2018).
- 19 American Diabetes Association. Standards of medical care in diabetes – 2017: summary of revisions. Diabetes Care 40(Suppl. 1), S4–S5 (2017).
- 20 . Transfer RNA Modifications: From Biological Functions to Biomedical Applications. In: Modified Nucleic Acids in Biology and Medicine. Jurga S, Erdmann VA, Barciszewski J (Eds). Springer International Publishing, Basel, Switzerland, 1–26 (2016).
- 21 . Recent advances in mitochondrial aminoacyl-trna synthetases and disease. Trends Mol. Med. 23(8), 693–708 (2017).
- 22 . Discovery and function of transfer RNA-derived fragments and their role in disease. Wiley Interdiscip. Rev. RNA. 8(5).
doi: 10.1002/wrna.1423 (2017). - 23 Mammostrat as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy. Breast Cancer. Res. 12(4), R47 (2010).
- 24 Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci. Mol. Cancer. 9, 100 (2010).
- 25 . GtRNAdb 2.0: an expanded database of transfer RNA genes identified in complete and draft genomes. Nucleic Acids Res. 44(D1), D184–D189 (2016).
- 26 . Characterizing expression and processing of precursor and mature human tRNAs by hydro-tRNAseq and PAR-CLIP. Cell Rep. 20(6), 1463–1475 (2017). • Reveals that not all of the tRNA genes encoded in the human genome are actively expressed.
- 27 Inosine modifications in human tRNAs are incorporated at the precursor tRNA level. Nucleic Acids Res. 43(10), 5145–5157 (2015).